ESR1 and breast cancer: These findings are interesting given that the previous reports showed FKBPL downregulating ERα expression in BC, leading to decreasing phosphorylation of ERα, and increasing sensitivity to tamoxifen; in addition, FKBPL expression was upregulated by estrogen treatment [14].